|
1
|
Giudice LC and Kao LC: Endometriosis.
Lancet. 364:1789–1799. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
D'Hooghe T and Forman A: European
accreditation of endometriosis centers of expertise? Gynecol Obstet
Invest. 76:1–3. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jenkins S, Olive DL and Haney AF:
Endometriosis: Pathogenetic implications of the anatomic
distribution. Obstet Gynecol. 67:335–338. 1986.PubMed/NCBI
|
|
4
|
Bhanoori M, Arvind Babu K, Pavankumar
Reddy NG, Lakshmi Rao K, Zondervan K, Deenadayal M, Kennedy S and
Shivaji S: The vascular endothelial growth factor (VEGF) +405G>C
5′-untranslated region polymorphism and increased risk of
endometriosis in South Indian women: A case control study. Hum
Reprod. 20:1844–1849. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Varma R, Rollason T, Gupta JK and Maher
ER: Endometriosis and the neoplastic process. Reproduction.
127:293–304. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Signorile PG and Baldi A: Endometriosis:
New concepts in the pathogenesis. Int J Biochem Cell Biol.
42:778–780. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trojanek J: Matrix metalloproteinases and
their tissue inhibitors. Postepy Biochem. 58:353–362. 2012.[(In
Polish)]. PubMed/NCBI
|
|
8
|
Ray JM and Stetler-Stevenson WG: The role
of matrix metalloproteases and their inhibitors in tumour invasion,
metastasis and angiogenesis. Eur Respir J. 7:2062–2072.
1994.PubMed/NCBI
|
|
9
|
Stetler-Stevenson WG, Liotta LA and
Kleiner DE Jr: Extracellular matrix 6: Role of matrix
metalloproteinases in tumor invasion and metastasis. FASEB J.
7:1434–1441. 1993.PubMed/NCBI
|
|
10
|
Osteen KG, Yeaman GR and Bruner-Tran KL:
Matrix metalloproteinases and endometriosis. Semin Reprod Med.
21:155–164. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rahmioglu N, Nyholt DR, Morris AP, Missmer
SA, Montgomery GW and Zondervan KT: Genetic variants underlying
risk of endometriosis: Insights from meta-analysis of eight
genome-wide association and replication datasets. Hum Reprod
Update. 20:702–716. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saare M, Lamp M, Kaart T, Karro H,
Kadastik U, Metspalu A, Peters M and Salumets A: Polymorphisms in
MMP-2 and MMP-9 promoter regions are associated with endometriosis.
Fertil Steril. 94:1560–1563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han YJ, Kim HN, Yoon JK, Yi SY, Moon HS,
Ahn JJ, Kim HL and Chung HW: Haplotype analysis of the matrix
metalloproteinase-9 gene associated with advanced-stage
endometriosis. Fertil Steril. 91:2324–2330. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rahmioglu N, Missmer SA, Montgomery GW and
Zondervan KT: Insights into Assessing the Genetics of
Endometriosis. Curr Obstet Gynecol Rep. 1:124–137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Collette T, Bellehumeur C, Kats R, Maheux
R, Mailloux J, Villeneuve M and Akoum A: Evidence for an increased
release of proteolytic activity by the eutopic endometrial tissue
in women with endometriosis and for involvement of matrix
metalloproteinase-9. Hum Reprod. 19:1257–1264. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH
and Lake Polan M: Matrix metalloproteinase-9 and tissue inhibitor
of metalloproteinase-3 mRNA expression in ectopic and eutopic
endometrium in women with endometriosis: A rationale for
endometriotic invasiveness. Fertil Steril. 75:152–159. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yunying Y, Xinhua G and Jinhua Q: The
expression of matrix metalloproteinase 9 and tissue inhibitor of
metalloproteinase 3 in endometriosis. Xian Dai Fu Chan Ke Jin Zhan.
12:25–27. 2003.[(In Chinese)].
|
|
18
|
Ria R, Loverro G, Vacca A, Ribatti D,
Cormio G, Roccaro AM and Selvaggi L: Angiogenesis extent and
expression of matrix metalloproteinase-2 and −9 agree with
progression of ovarian endometriomas. Eur J Clin Invest.
32:199–206. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang B, Henney A, Eriksson P, Hamsten A,
Watkins H and Ye S: Genetic variation at the matrix
metalloproteinase-9 locus on chromosome 20q12.2–13.1. Hum Genet.
105:418–423. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, Ye S, Herrmann SM, Eriksson P, de
Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, et al:
Functional polymorphism in the regulatory region of gelatinase B
gene in relation to severity of coronary atherosclerosis.
Circulation. 99:1788–1794. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chung HW, Lee JY, Moon HS, Hur SE, Park
MH, Wen Y and Polan ML: Matrix metalloproteinase-2, membranous type
1 matrix metalloproteinase and tissue inhibitor of
metalloproteinase-2 expression in ectopic and eutopic endometrium.
Fertil Steril. 78:787–795. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang HF, Hong LH, Tan Y and Sheng JZ:
Matrix metalloproteinase 2 is associated with changes in steroid
hormones in the sera and peritoneal fluid of patients with
endometriosis. Fertil Steril. 81:1235–1239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang S, Zhao XW, Wang N, Chen SC, Zhou RM
and Li Y: Association of polymorphisms of the MMP-2 and TIMP-2
genes with the risk of endometriosis in North Chinese women. Fertil
Steril. 90:2023–2029. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lau J, Ioannidis JP and Schmid CH:
Quantitative synthesis in systematic reviews. Ann Intern Med.
127:820–826. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
27
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yarmolinskaya M, Molotkov A, Bezhenar V,
Shved NY, Ivaschenko T and Baranov V: Matrix metalloproteinases's
association of polymorphisms of MMP3 and MMP9 with development of
genital endometriosis. Russ J Genet. 50:205–210. 2014. View Article : Google Scholar
|
|
30
|
Qu Y, Li Y and Yang M: Association of
polymorphisms of the MMP 9 with the risk of endometriosis and
adenomyosis. Zhong Guo Mei Tan Gong Ye Yi Xue Za Zhi. 10:1079–1080.
2007.[(In Chinese)].
|
|
31
|
Zhou M, Guo R, Zeng X, Wang C, Luo Y and
Huang X: Correlation between promoter polymorphism of MMP 2 and
susceptibility of endometriosis. Hai Nan Yi Xue Yuan Xue Bao.
19:15–17. 2013.[(In Chinese)].
|
|
32
|
Fidler IJ and Radinsky R: Genetic control
of cancer metastasis. J Natl Cancer Inst. 82:166–168. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Guo X, Yu S, Song J, Zhang J, Cao
Z, Wang J, Liu M and Dong W: Association between CD14 gene
polymorphisms and cancer risk: A meta-analysis. PLoS One.
9:e1001222014. View Article : Google Scholar : PubMed/NCBI
|
